Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases

Background. Type 2 diabetes (Т2DM) both directly and indirectly impacts the development of morphological and functional changes of the central nervous system. Aim. The study was to determine clinical and neurophysiological patterns of cognitive impairment (CI) in patients with chronic cerebrovasc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marine M. Tanashyan, Elena V. Surkova, Kseniia V. Antonova, Olga V. Lagoda, Alexander V. Naminov, Elena S. Berdnikovich, Pavel A. Fedin, Irina I. Titkova
Formato: article
Lenguaje:RU
Publicado: "Consilium Medicum" Publishing house 2021
Materias:
R
Acceso en línea:https://doaj.org/article/7efc5b2f63a741498ff25c1dc1a7c3fc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7efc5b2f63a741498ff25c1dc1a7c3fc
record_format dspace
spelling oai:doaj.org-article:7efc5b2f63a741498ff25c1dc1a7c3fc2021-12-01T12:22:36ZType 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases0040-36602309-534210.26442/00403660.2021.10.201108https://doaj.org/article/7efc5b2f63a741498ff25c1dc1a7c3fc2021-10-01T00:00:00Zhttps://ter-arkhiv.ru/0040-3660/article/viewFile/86920/65107https://doaj.org/toc/0040-3660https://doaj.org/toc/2309-5342Background. Type 2 diabetes (Т2DM) both directly and indirectly impacts the development of morphological and functional changes of the central nervous system. Aim. The study was to determine clinical and neurophysiological patterns of cognitive impairment (CI) in patients with chronic cerebrovascular diseases (CCD) and Т2DM. Materials and methods. We examined 132 patients with CCD. First group included 58 patients without Т2DM aged 64.5 [58; 72], second group 74 patients with CCD and Т2DM 63 [57; 70]. Clinical, neurological, neuropsychological, neurophysiological (cognitive evoked potentials (EP) and neurovisualisation (brain MRI) examination was carried out to all patients. Results. Somatic and neurological characteristics of the patients were similar in both groups with the exception of more distinct metabolic changes in Т2DM patients. Neurovisualisation study of the brain MRI in Т2DM patients revealed more distinct changes in the form of white matter hyperintensity and subarachnoidal spaces enlargement. Neuropsychological examination in patients revealed the reduction of intellectual flexibility, constructive praxis disruption, optical spatial dysfunction and deteoration of delayed word recall. Significant disorders in the way of overall cognitive impairment, lobar dysfunction and impaired verbal associative productivity, proved by statistically lower amplitude and higher latency of P300 EP peak were noted in Т2DM patients. Correlation links were detected: for P300 amplitude and direct and inverse number listing test (r=0.366 and r=0.520; p=0.006 and p0.001 respectively); P300 latency and HbA1c (r=0.32; р0.05) in group 2 and glucose levels in both groups (r=0.30; p0.05); inverse relationship of latency with control functions evaluation (r=-0.34; p=0.008). Conclusion. CCD especially with Т2DM manifests with neurocognitive imbalance, including control functions disruption and are accompanied by neurophysiological and neurovisualistion changes.Marine M. TanashyanElena V. SurkovaKseniia V. AntonovaOlga V. LagodaAlexander V. NaminovElena S. BerdnikovichPavel A. FedinIrina I. Titkova"Consilium Medicum" Publishing housearticlecerebrovascular diseasesdiabetes mellutiscognitive impairmentevoked potentialsneuropsychological disordersMedicineRRUТерапевтический архив, Vol 93, Iss 10, Pp 1179-1185 (2021)
institution DOAJ
collection DOAJ
language RU
topic cerebrovascular diseases
diabetes mellutis
cognitive impairment
evoked potentials
neuropsychological disorders
Medicine
R
spellingShingle cerebrovascular diseases
diabetes mellutis
cognitive impairment
evoked potentials
neuropsychological disorders
Medicine
R
Marine M. Tanashyan
Elena V. Surkova
Kseniia V. Antonova
Olga V. Lagoda
Alexander V. Naminov
Elena S. Berdnikovich
Pavel A. Fedin
Irina I. Titkova
Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
description Background. Type 2 diabetes (Т2DM) both directly and indirectly impacts the development of morphological and functional changes of the central nervous system. Aim. The study was to determine clinical and neurophysiological patterns of cognitive impairment (CI) in patients with chronic cerebrovascular diseases (CCD) and Т2DM. Materials and methods. We examined 132 patients with CCD. First group included 58 patients without Т2DM aged 64.5 [58; 72], second group 74 patients with CCD and Т2DM 63 [57; 70]. Clinical, neurological, neuropsychological, neurophysiological (cognitive evoked potentials (EP) and neurovisualisation (brain MRI) examination was carried out to all patients. Results. Somatic and neurological characteristics of the patients were similar in both groups with the exception of more distinct metabolic changes in Т2DM patients. Neurovisualisation study of the brain MRI in Т2DM patients revealed more distinct changes in the form of white matter hyperintensity and subarachnoidal spaces enlargement. Neuropsychological examination in patients revealed the reduction of intellectual flexibility, constructive praxis disruption, optical spatial dysfunction and deteoration of delayed word recall. Significant disorders in the way of overall cognitive impairment, lobar dysfunction and impaired verbal associative productivity, proved by statistically lower amplitude and higher latency of P300 EP peak were noted in Т2DM patients. Correlation links were detected: for P300 amplitude and direct and inverse number listing test (r=0.366 and r=0.520; p=0.006 and p0.001 respectively); P300 latency and HbA1c (r=0.32; р0.05) in group 2 and glucose levels in both groups (r=0.30; p0.05); inverse relationship of latency with control functions evaluation (r=-0.34; p=0.008). Conclusion. CCD especially with Т2DM manifests with neurocognitive imbalance, including control functions disruption and are accompanied by neurophysiological and neurovisualistion changes.
format article
author Marine M. Tanashyan
Elena V. Surkova
Kseniia V. Antonova
Olga V. Lagoda
Alexander V. Naminov
Elena S. Berdnikovich
Pavel A. Fedin
Irina I. Titkova
author_facet Marine M. Tanashyan
Elena V. Surkova
Kseniia V. Antonova
Olga V. Lagoda
Alexander V. Naminov
Elena S. Berdnikovich
Pavel A. Fedin
Irina I. Titkova
author_sort Marine M. Tanashyan
title Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
title_short Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
title_full Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
title_fullStr Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
title_full_unstemmed Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
title_sort type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases
publisher "Consilium Medicum" Publishing house
publishDate 2021
url https://doaj.org/article/7efc5b2f63a741498ff25c1dc1a7c3fc
work_keys_str_mv AT marinemtanashyan type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT elenavsurkova type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT kseniiavantonova type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT olgavlagoda type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT alexandervnaminov type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT elenasberdnikovich type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT pavelafedin type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
AT irinaititkova type2diabetesandcognitivefunctionsinpatientswithchroniccerebrovasculardiseases
_version_ 1718405182342037504